Sunrise Reports Financial Results for First-Quarter 2009
...terminated on April 30, 2009. Sunrise received proceeds of approximately $5.2 million for its equity interest and its receivable from the venture for fundings under the operating deficit guarantees. Operating Data for First-Quarter 2009 The Aston Gardens portfolio has been excluded from Sunrise ...Sunrise Receives Proceeds from Venture Refinancing
...es; risk of changes in the Company's critical accounting estimates; risk of further write-downs or impairments of the Company's assets; risk of future fundings of guarantees and other support arrangements to some of the Company's ventures, lenders to the ventures or third party owners; risk of declining occup...Sunrise Reports Financial Results for Third Quarter 2008
...any is still responsible for guarantee liabilities to the lenders. Future fundings to Sunrise's German operations for operating losses and interest payments e... further write-downs or impairments of the Company's assets; risk of future fundings of guarantees and other support arrangements to some of the Company's ventu...Sunrise Provides Update on HCN Transaction
...ties by ventures; risk of changes in Sunrise's critical accounting estimates; risk of further write-downs or impairments of its assets; risk of future fundings of guarantees and other support arrangements to some of its ventures, lenders to the ventures or third party owners; risk of declining occupancies in ...IHHI Announces Second Quarter Earnings
... funding for indigent care, and $3.0 million and $3.5 million during the six months ended September 30, 2007 and 2006, respectively. Such supplemental fundings may or may not occur in future periods. Management commented further that the improved operating results do not yet reflect the reduced borrowing cost...Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
CLARKSVILLE, Md., Oct. 13 /PRNewswire/ -- Neuronascent, Inc. ( http://www.neuronascent.com ) announced today that the Company has received funding from multiple sources to further the development of its novel, neurogenic compounds targeting Alzheimer's disease, depression and ischemia. Neurona...Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
ROCKVILLE, Md., Dec. 26 /PRNewswire/ -- Sirnaomics, Inc. announced today that the company has received funding from a variety of Government Programs. Sirnaomics, Inc. (http://www.sirnaomics.com ), a biopharmaceutical company founded in early 2007, dedicates to advancing RNA interference (RNAi...